PRF Technologies Ltd. (PRFX) is up 215.3% today. Here is some analysis on what might have caused this price movement.
Analysis: The move appears tied to a burst of momentum following company updates on its DeepSolar Predict renewable-energy optimization platform, alongside separate preclinical results for its PRF-110 non-opioid post-surgical pain candidate. Given PRFX’s micro-cap profile and historically high volatility, the rally may also reflect thin liquidity and headline-driven trading rather than a single fundamental revaluation.
Details:
Sources:
GlobeNewswire, U.S. SEC (EDGAR), Investing.com
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$PRFX Hedge Fund Activity
We have seen 2 institutional investors add shares of $PRFX stock to their portfolio, and 5 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC added 13,220 shares (+inf%) to their portfolio in Q1 2026, for an estimated $26,770
- TWO SIGMA SECURITIES, LLC removed 4,269 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $8,644
- MORGAN STANLEY removed 3,509 shares (-68.5%) from their portfolio in Q1 2026, for an estimated $7,105
- UBS GROUP AG removed 3,470 shares (-80.0%) from their portfolio in Q1 2026, for an estimated $7,026
- XTX TOPCO LTD removed 2,692 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $5,451
- SBI SECURITIES CO., LTD. removed 6 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $12
- OSAIC HOLDINGS, INC. added 1 shares (+2.6%) to their portfolio in Q1 2026, for an estimated $2
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.